Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives.
Rath S, Liebl J, Fürst R, Ullrich A, Burkhart JL, Kazmaier U, Herrmann J, Müller R, Günther M, Schreiner L, Wagner E, Vollmar AM, Zahler S.
Rath S, et al. Among authors: kazmaier u.
Br J Pharmacol. 2012 Nov;167(5):1048-61. doi: 10.1111/j.1476-5381.2012.02037.x.
Br J Pharmacol. 2012.
PMID: 22595030
Free PMC article.